세포 및 유전자 치료 제조 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Cell & Gene Therapy Manufacturing Services Market size is expected to reach USD 134.08 Billion in 2034 from USD 15.76 Billion (2025) growing at a CAGR of 26.86% during 2026-2034.

The global cell and gene therapy manufacturing services market is experiencing rapid growth due to the increasing focus on advanced therapeutics for complex diseases. These therapies offer targeted treatment options for conditions such as cancer and genetic disorders, driving demand for specialized manufacturing services. The growing number of clinical trials and regulatory approvals is further boosting market expansion. Additionally, advancements in biotechnology are enhancing production capabilities and scalability.

Key drivers include rising investments in research and development and the increasing involvement of pharmaceutical and biotechnology companies. Outsourcing manufacturing services allows companies to reduce costs and focus on innovation. The growing demand for personalized medicine and regenerative therapies is also fueling market growth. Furthermore, improvements in manufacturing technologies and regulatory support are enabling efficient production and commercialization of these therapies.

Looking ahead, the cell and gene therapy manufacturing services market is expected to witness substantial growth as more therapies receive approval and enter the market. Technological advancements in automation and bioprocessing will improve efficiency and scalability. Increasing collaborations between biotech firms and contract manufacturing organizations will further drive innovation. Emerging markets are likely to offer significant growth opportunities due to expanding healthcare infrastructure and rising investment in advanced therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapy Type

• Cell Therapy Manufacturing (Stem Cell Therapy, Non-Stem Cell Therapy)
• Gene Therapy Manufacturing

By Scale

• Pre-Commercial/R&D Scale Manufacturing
• Commercial Scale Manufacturing

By Mode

• Contract Manufacturing
• In-House Manufacturing

By Workflow

• Cell Processing
• Cell Banking
• Process Development
• Fill & Finish Operations
• Analytical And Quality Testing
• Raw Material Testing
• Vector Production
• Others

COMPANIES PROFILED

• Lonza, Bluebird Bio Inc, Catalent Inc, F HoffmannLa Roche Ltd, Samsung Biologics, Boehringer Ingelheim, Cellular Therapeutics, Hitachi Chemical Co Ltd, Takara Bio Inc, Miltenyi Biotec
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: BY THERAPY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapy Type
• 4.2. Cell Therapy Manufacturing (Stem Cell Therapy, Non-Stem Cell Therapy) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Gene Therapy Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: BY SCALE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Scale
• 5.2. Pre-Commercial/R&D Scale Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Commercial Scale Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: BY MODE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode
• 6.2. Contract Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. In-House Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Workflow
• 7.2. Cell Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Cell Banking Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Process Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Fill & Finish Operations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Analytical And Quality Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Raw Material Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Vector Production Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Therapy Type
  • 8.2.2 By Scale
  • 8.2.3 By Mode
  • 8.2.4 By Workflow
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Therapy Type
  • 8.3.2 By Scale
  • 8.3.3 By Mode
  • 8.3.4 By Workflow
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Therapy Type
  • 8.4.2 By Scale
  • 8.4.3 By Mode
  • 8.4.4 By Workflow
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Therapy Type
  • 8.5.2 By Scale
  • 8.5.3 By Mode
  • 8.5.4 By Workflow
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Therapy Type
  • 8.6.2 By Scale
  • 8.6.3 By Mode
  • 8.6.4 By Workflow
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Lonza
  • 10.2.2 Bluebird Bio Inc
  • 10.2.3 Catalent Inc
  • 10.2.4 F. Hoffmann-La Roche Ltd
  • 10.2.5 Samsung Biologics
  • 10.2.6 Boehringer Ingelheim
  • 10.2.7 Cellular Therapeutics
  • 10.2.8 Hitachi Chemical Co. Ltd
  • 10.2.9 Takara Bio Inc
  • 10.2.10 Miltenyi Biotec